SCHEMBL8759028

SCHEMBL8759028

Cc1ccc(-c2c(NS(=O)(=O)c3ccccc3)n[nH]c2C(F)(F)F)cc1C.O=S(=O)(Nc1n[nH]c(C(F)(F)F)c1-c1cc(Cl)ccc1Cl)c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 2/20 0.39
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
HTT P42858 2/20 0.36
LMNA P02545 1/20 0.36
POLB P06746 1/20 0.36
ACLY P53396 2/20 0.36
KMO O15229 1/20 0.35
PTGES2 Q9H7Z7 1/20 0.35
PGR P06401 1/20 0.35
MAPT P10636 1/20 0.35
SGK1 O00141 2/20 0.34
KDM1A O60341 1/20 0.34
IDH1 O75874 2/20 0.34
CHUK O15111 1/20 0.34
ALDH1A1 P00352 2/20 0.34
GAA P10253 1/20 0.34
ALOX15 P16050 1/20 0.34
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8628709 0.90 ERBB2 (0.40) MEN1KMT2ATDP1LMNAPOLB
SCHEMBL8634594 0.89 FFAR4 (0.39) MEN1KMT2ATDP1HTTLMNA
SCHEMBL8631571 0.83 KMO (0.47) MEN1KMT2ATDP1KMOPTGES2
SCHEMBL8629094 0.82 ERBB2 (0.40) MEN1KMT2ATDP1LMNAPOLB
SCHEMBL8632682 0.82 KDM1A (0.46) MEN1KMT2AHTTLMNAPOLB
SCHEMBL8627699 0.81 MAPK14 (0.40) MEN1KMT2ATDP1LMNASGK1
SCHEMBL8634847 0.81 NAT1 (0.46) MEN1KMT2ALMNAACLYPGR
SCHEMBL8635286 0.80 NAT1 (0.44) MEN1KMT2ATDP1HTTLMNA
SCHEMBL8629227 0.79 ALDH1A1 (0.43) MEN1KMT2AHTTLMNAPOLB
SCHEMBL8628728 0.78 CCR2 (0.39) MEN1KMT2ATDP1HTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
WO-1996003385-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed